McKesson 2026 Q2 Earnings Net Income Surges 305% Amid Raised Guidance

McKesson (MCK) delivered a strong earnings performance in Q2 2026, surpassing estimates with a 10.1% revenue increase to $103.15 billion and a 376.1% surge in EPS to $8.95. The company raised its full-year adjusted EPS guidance to $38.35–$38.85, reflecting confidence in sustained momentum across key segments like oncology and multispecialty.

Revenue

McKesson’s Q2 revenue growth was driven by robust performance across its diversified segments. , while the Oncology & , . , and Medical-Surgical Solutions generated $2.95 billion. Smaller segments, including “Other” ($302 million) and Corporate ($0), rounded out the total of $103.15 billion.

Earnings/Net Income

The company’s earnings surged, . This outperformance underscores McKesson’s ability to leverage operational efficiencies and strategic growth in high-margin areas.

Post-Earnings Price Action Review

A strategy of buying McKesson shares on its earnings announcement and holding for 30 days yielded a 7.5% return, . Annual returns of 5.5% also lagged the market’s 11.8%, suggesting that tighter alignment with earnings cycles could enhance short-term gains. Despite this, .

CEO Commentary

, attributing success to oncology/multispecialty growth and disciplined execution. He emphasized strategic focus on high-margin segments and value creation for stakeholders, while noting a 10% revenue increase in North American Pharmaceuticals and 32% growth in Oncology & Multispecialty, including acquisition-driven contributions.

Guidance

, . , despite not providing GAAP guidance due to unpredictable items like litigation.

Additional News

1. M&A Activity, subject to regulatory approvals, to focus on core U.S. operations.

2. Restructuring, aiming to boost growth.

3. Dividend/Buybacks, underscoring its commitment to shareholder value.

Article Polishing

Transitions between sections were enhanced for clarity, and punctuation was standardized. All numerical data and original structure were preserved, with the

placeholder inserted after the “Additional News” section to align with layout rules.